NIOSH Risk Assess and PPE requirements

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Thu, 02/07/2019 - 10:34
#1
Karin Terry
Karin Terry's picture
Offline
Last seen: 2 months 4 days ago
Joined: 02/02/2009 - 08:13
NIOSH Risk Assess and PPE requirements

I was hoping to get some insight from all of you who have already implemented USP 800. We are closing in on our final details for implementation, but we have one sticking point among the workgroup and the leadership group.

Part of my team wants to keep all drugs on the original NIOSH list and do all required PPE. Part of my team wants to risk-assess and move a lot of "final dosage forms" from Table 2 to the Reproductive Category, as well as decrease required PPE. They are afraid of resource wasting and overkill/"PPE alert fatigue".

I have found a lot of lists from various facilities where drugs are being moved to allow for less PPE. What is everyone doing to get buy-in for that move?
Has anyone who has moved drugs or decreased required PPE gone through surveys and gotten feedback positive or negative?

Thanks so much for any insight you can provide!
Karin Terry
Medication Safety Officer
OSF HealthCare

Top